The success of Sildenafil initially fueled a period of growth for pharma, but recent changes present a uncertain scenario for shareholders. Generic alternatives are eating into profits, and persistent legal battles add https://ammarbqye978317.blogpayz.com/41467620/viagra-and-the-pharmaceutical-industry-a-risky-investment